
CAS: 578727-68-1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | MK 0686 REF: TR-M424845CAS: 578727-68-1 | - - - | 16,483.00 € | Tue 27 May 25 |
![]() | MK-0686 REF: TM-T33421CAS: 578727-68-1 | 99.56% | 182.00 €~3,734.00 € | Tue 03 Jun 25 |
![]() | MK 0686 REF: 3D-DYA72768CAS: 578727-68-1 | Min. 95% | - - - | Discontinued product |

MK 0686
Controlled ProductCAS:578727-68-1
Formula:
C22H19ClF4N2O4
Color and Shape:
Neat
Molecular weight:
486.844
Ref: TR-M424845
100mg | 16,483.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025

MK-0686
CAS:578727-68-1
MK-0686 is an orally available bradykinin B1 receptor antagonist with potential anti-inflammatory activity.
Formula:
C22H19ClF4N2O4
Purity:
99.56%
Color and Shape:
Liquid
Molecular weight:
486.84
Ref: TM-T33421
1mg | 182.00 € | ||
5mg | 447.00 € | ||
10mg | 655.00 € | ||
25mg | 1,026.00 € | ||
50mg | 1,388.00 € | ||
100mg | 1,863.00 € | ||
500mg | 3,734.00 € |
Estimated delivery in United States, on Tuesday 3 Jun 2025

MK 0686
CAS:578727-68-1
MK 0686 is a novel drug candidate that belongs to the class of conjugates. It …
Formula:
C22H19ClF4N2O4
Purity:
Min. 95%
Molecular weight:
486.8 g/mol
Ref: 3D-DYA72768
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |